Neodymium-yag laser vitreolysis in sickle cell retinopathy

Nick F. Hrisomalos, Lee M. Jampol, Brendan J. Moriarty, Graham Serjeant, Robert Acheson, Morton F. Goldberg

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


Six patients with proliferative sickle cell retinopathy and vitreous bands were treated with the neodymium-YAG (Nd-YAG) laser to accomplish lysis of avascular traction bands or to clear the media in front of the macula. Transection of bands was possible in five of the six cases but in two of these the effect was only partial. Three cases were satisfactorily treated with the Nd-YAG laser application alone, two eventually required conventional vitreoretinal surgery, and one patient's condition stabilized despite failure of the treatment. Complications from the treatment occurred in three cases and included subretinal (choroidal) hemorrhage, preretinal hemorrhage, microperforation of a retinal vein, and focal areas of damage to the retinal pigment epithelium. Neodymium-YAG vitreolysis may be a useful modality in carefully selected patients with proliferative sickle cell retinopathy, but potentially sight-threatening complications may occur.

Original languageEnglish (US)
Pages (from-to)1087-1091
Number of pages5
JournalArchives of ophthalmology
Issue number8
StatePublished - Aug 1987

ASJC Scopus subject areas

  • Ophthalmology

Fingerprint Dive into the research topics of 'Neodymium-yag laser vitreolysis in sickle cell retinopathy'. Together they form a unique fingerprint.

Cite this